Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
OBJECTIVE
The aim of this study is to describe recommendations made by clinical pharmacists when co-managing hypertension with physicians.


METHODS
Two family medicine clinics at a major teaching hospital in the mid-western United States.


METHODS
This report details the specific recommendations made by pharmacists during a prospective randomized controlled clinical trial. Patients with uncontrolled hypertension were enrolled in a 9-month intensive pharmacist-physician co-management study. Clinical pharmacists saw patients at baseline, 2, 4, 6, and 8 month visits. Optional visits were allowed between required visits.


METHODS
For this analysis, pharmacist recommendations were grouped. Physician acceptance of the pharmacists' recommendations was also evaluated.


RESULTS
Data from 101 patients were included and analyzed in this study. Changes in drug therapy were recommended 267 times for these 101 patients. Most recommendations for a change in treatment involved adding a new antihypertensive medication (46.4%) or increasing a dose (33.3%). The majority of pharmacist recommendations to modify drug therapy were made at the baseline visit (41.6%), with 76.8% of recommendations made by the 2 month visit. Physicians accepted and implemented 95.9% of the 267 pharmacist recommendations to modify drug therapy. Pharmacists recommended no change in the treatment plan 361 times, most often because the patient's blood pressure (BP) had achieved the goal. Average BP decreased from 153.1+/-10.0/84.9+/-12.0 mmHg (average+/-SD) at baseline to 124.2+/-9.7/74.7+/-9.6 mmHg (P<0.001) at the end of 9 months, with 89.1% (P<0.001) of patients reaching their BP goal.


CONCLUSIONS
Pharmacist recommendations for alterations in drug therapy generally occurred early in the course of the study and were largely to intensify therapy through higher dosages or additional medications. Pharmacist-physician co-management of BP is effective at reducing BP and improving BP control rates.
Von Muenster
Shannon J
SJ
Division of Clinical and Administrative Pharmacy, Room 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
Carter
Barry L
BL
Weber
Cynthia A
CA
Ernst
Michael E
ME
Milchak
Jessica L
JL
Steffensmeier
Jennifer J G
JJ
Xu
Yinghui
Y
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006784:Hospitals, Teaching; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007400:Interprofessional Relations; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D010595:Pharmacists; D010607:Pharmacy Service, Hospital; D010820:Physicians; D024382:Professional Role; D011446:Prospective Studies; D014481:United States
D000959:Antihypertensive Agents
N Engl J Med. 2001 Aug 16;345(7):479-86
11519501
Hypertension. 2003 Dec;42(6):1206-52
14656957
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
J Clin Hypertens (Greenwich). 2008 Apr;10(4):260-71
18401223
J Am Pharm Assoc (Wash). 1996 Jul;NS36(7):443-51
8840744
Med Care. 1983 Apr;21(4):435-44
6843196
Am J Hosp Pharm. 1979 Jul;36(7):912-5
474579
Hypertension. 2005 Jan;45(1):142-61
15611362
J Hypertens. 2003 Jun;21(6):1011-53
12777938
N Engl J Med. 1998 Dec 31;339(27):1957-63
9869666
J Gen Intern Med. 2005 Dec;20(12):1091-6
16423096
J Am Pharm Assoc. 1974 Apr;14(4):190-5
4819535
Am J Hosp Pharm. 1979 Oct;36(10):1321-5
507073
Pharmacotherapy. 2003 Feb;23(2):209-16
12587810
Pharmacotherapy. 2002 Dec;22(12):1533-40
12495164
Hypertension. 2001 Jan;37(1):12-18
11208750
J Am Pharm Assoc (2003). 2004 May-Jun;44(3):337-49
15191244
Ann Pharmacother. 2000 Jun;34(6):772-87
10860139
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):31-7
12556651
Arch Intern Med. 1981 Oct;141(11):1441-4
7283555
Arch Intern Med. 2002 Feb 25;162(4):413-20
11863473
Pharmacotherapy. 1997 Jan-Feb;17(1):140-7
9017775
Pharmacotherapy. 1997 Nov-Dec;17(6):1274-85
9399611
Arch Intern Med. 1984 Jun;144(6):1159-62
6732373
Lancet. 1998 Jun 13;351(9118):1755-62
9635947
DICP. 1990 Mar;24(3):304-9
2316237
J Gen Intern Med. 1998 Nov;13(11):740-5
9824519
Circulation. 1973 Nov;48(5):1104-11
4201656
Hypertension. 2001 Jan;37(1):19-27
11208751
JAMA. 2006 Dec 6;296(21):2563-71
17101639
JAMA. 2002 Nov 20;288(19):2421-31
12435255
Pharmacotherapy. 2000 Nov;20(11):1384-9
11079287
Educ Health (Abingdon). 2003 Jul;16(2):230
14741909
Am J Hosp Pharm. 1988 Apr;45(4):824-7
3376965
Rev Clin Esp. 2006 Nov;206(10):510-4
17129520
Circulation. 1997 Feb 18;95(4):1085-90
9054774
Med Care. 2006 Jul;44(7):646-57
16799359
Can J Cardiol. 2005 May 15;21(7):589-93
15940357
Hypertension. 2007 Jan;49(1):69-75
17159087